Search for: "HIKMA PHARMACEUTICALS PLC" Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Judge Robinson Grants Takeda’s Temporary Restraining Order Against Defendants Attempting to Launch Generic Colchicine Product
11 Oct 2014, 11:51 am by Gregory B. Williams
West-Ward Pharmaceuticals Corp., et al., Civil Action No. 14-1268-SLR (D.Del., October 9, 2014), the Court granted plaintiff Takeda’s motion for a temporary restraining order (“TRO”) against defendants, West-Ward Pharmaceutical Corporation, Hikma Americas Inc., and Hikma Pharmaceuticals PLC, to preserve the status quo with respect to the launch of defendants’ generic colchicine product as of October 9, 2014 while the court… [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Drug Maker Agrees to Divest Two Medicines to Win FTC Acquisition Approval
27 Apr 2011, 10:23 am by Jenna Greene
Speciality drug maker Hikma Pharmaceuticals PLC agreed to divest two generic injectable medicines to win Federal Trade Commission approval of its $111 million acquisition of Baxter Healthcare Corp. [read post]
The BLT: Blog of Legal Times - http://legaltimes.typepad.com/blt/
Patently-O Bits and Bytes by Juvan Bonni
12 Sep 2022, 6:00 pm by Juvan Bonni
Hikma Type Litigation (Source: SSRN) Prof. [read post]
Patently-O - https://patentlyo.com
Davis Polk Discusses Biden’s Executive Order on Competition, One Year Later
29 Aug 2022, 9:05 pm by Sheila R. Adams, Cody Donald, Benjamin M. Miller, Suzanne Munck af Rosenschold and Nathan Kiratzis
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
The CLS Blue Sky Blog - https://clsbluesky.law.columbia.edu/